Comparative Effectiveness of Rituximab in Combination with Either Methotrexate or Leflunomide in the Treatment of Rheumatoid Arthritis

Seminars in Arthritis and Rheumatism

Volumn 41, Issue 3, 2011, Pages 401-405

  Narváez, Javier ^a   Díaz Torné, César ^b   Ruiz, José Miguel ^c   Hernández, Maria Victoria ^d   Torrente Segarra, Vicens ^b   Ros, Sergio ^c   Rodriguez de la Serna, Arturo ^b   Díaz López, César ^b   Sanmartí, Raimon ^d   Nolla, Joan Miquel ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c HOSPITAL DE VILADECANS   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

Leflunomide; Methotrexate; Rheumatoid arthritis; Rituximab

Indexed keywords

LEFLUNOMIDE; METHOTREXATE; RITUXIMAB;

ADULT; ARTHRALGIA; ARTICLE; COMPARATIVE EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE IN 28 JOINTS; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EUROPEAN LEAGUE AGAINST RHEUMATISM IMPROVEMENT CRITERIA; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALAISE; MALE; MYALGIA; NAUSEA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

ADULT; AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; ISOXAZOLES; MALE; METHOTREXATE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 82955195732     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2011.06.005     Document Type: Article

References (12)

1. Bagust A., Boland A., Hockenhull J., Fleeman N., Greenhalgh J., Dundar Y., et al. Rituximab for the treatment of rheumatoid arthritis. Health Technol Assess 2009, 13(Suppl 2):23-29.
2. Maddison P., Kiely P., Kirkham B., Lawson T., Moots R., Proudfoot D., et al. Leflunomide in rheumatoid arthritis: recommendations through a process of consensus. Rheumatology (Oxford) 2005, 44:280-286.
3. Finckh A., Dehler S., Gabay C. The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoide arthritis: a population-based study. Ann Rheum Dis 2009, 68:33-39. SCQM doctors.
4. Strangfeld A., Hierse F., Ketov J., von Hinueber U., Tony H.P., Docjhorn R., et al. Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide. Ann Rheum Dis 2009, 68:1856-1862.
5. De Stefano R., Frati E., Nargi F., Baldi C., Menza L., Hammond M., et al. Comparison of combination therapies in the treatment of rheumatoid arthritis: leflunomide-anti TNF alpha versus methotrexate.anti TNF alpha. Clin Rheumatol 2010, 29:517-524.
6. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
7. Van Gestel A.M., Haagsma C.J., van Riel P.L. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998, 41:1845-1850.
8. Wendler J., Soerensen H., Tony H., Richter C., Krauss A., Rubbert-Roth A., et al. Effectiveness and safety of rituximab monotherapy compared to rituximab combination therapy with methotrexate or leflunomide in the german rituximab treatment of active rheumatoid arthrtitis in daily practice trial [abstract]. Ann Rheum Dis 2009, 68(Suppl 3):76.
9. Gabay C., Chatzidionysiou K., Nosonov E., Lukina G., Hetland M.L., Tarp U., et al. Effectiveness of different DMARD cotherapies in rituximab-treated rheumatoid arthritis patients: results of a one-year follow-up study from the CERRERA collaboration [abstract]. Ann Rheum Dis 2010, 69(Suppl 3):68.
10. Lukina G., Sigidin I.A., Aseeva E.A., Glukhova S.I., Nasonov E.L. Rituximab combinations in rheumatoid arthritis patients; methotrexate versus leflunomide [abstract]. Ann Rheum Dis 2010, 69(Suppl 3):536. ARBITER Study Group.
11. Henes J.C., Schedel J., Kanz L., Koetter I. Rituximab and concomitant leflunomide for the treatment of rheumatoid arthritis. Rheumatol Int 2010, 30:709-712.
12. Vital E.M., Dass S., Rawstron A.C., Emery P. Combination rituximab and leflunomide produces lasting responses in rheumatoid arthritis [abstract]. Ann Rheum Dis 2008, 67(Suppl II):90.